Background: In July 2022, human monkeypox (Mpox) was declared by the World Health Organization public health emergency of global concern. Assessing people's knowledge about Mpox will help the government and healthcare workers create policies to prevent the spread of the virus. To the best of my knowledge, this is the first study that assessed Filipinos' Mpox knowledge. Thus, this study investigated the Filipinos' Mpox knowledge and determined the demographic variables that predicted it.
Methods: A descriptive cross-sectional design study participated by 557 Filipinos. This study used a 21-item Mpox knowledge survey questionnaire to collect data from July to September 2022. Logistic regression analysis was used to analyze the data.
Results: Most participants (53.74%) were above 30 years old, females (68.87%), residing in Luzon (54.96%), college graduates (61.04%), Catholics (78.61%), and employed (68%). Social media, particularly Facebook (57.91%), is the common source of Mpox-related information (78.61%). Participants' age (>30 years old) is the only predictor of Mpox infection knowledge (aOR: 3.13; 95%CI: 1.25-7.87, = 0.015). They are three times more likely to be knowledgeable than those under 30.
Conclusion: The findings highlight the importance of evidence-based strategies for increasing public knowledge and awareness. The government, healthcare workers, and the public should adopt proactive preventive measures against Mpox to prevent future pandemics.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938543 | PMC |
http://dx.doi.org/10.1016/j.heliyon.2023.e13864 | DOI Listing |
Curr Med Res Opin
December 2024
Department of Medical Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Objective: The recent outbreak of monkeypox (mpox) poses significant public health challenges, particularly for immunocompromised populations such as patients with cancer. However, misinformation poses a significant challenge during new outbreaks for patients with chronic diseases, as observed during the COVID-19 pandemic. Therefore, we aimed to assess perspectives and knowledge of patients with cancer on mpox and their willingness to receive mpox vaccination.
View Article and Find Full Text PDFJ Med Virol
December 2024
SR Sanjeevani Hospital, Kalyanpur, Siraha, Nepal.
Mpox, formerly known as monkeypox, has re-emerged as a significant global health concern, particularly during the widespread outbreak of 2022. As an orthopoxvirus related to the eradicated smallpox virus, mpox has been primarily managed with smallpox vaccines and treatments, including the antiviral agent Tecovirimat. This systematic review aims to evaluate the effectiveness and safety of Tecovirimat in treating mpox, focusing on its use during the 2022 outbreak, especially among high-risk populations, including men who have sex with men and people living with HIV.
View Article and Find Full Text PDFBiomed J
December 2024
College of Medicine, Chang Gung University, Taoyuan, Taiwan; Division of Infectious Diseases, Department of Medicine, Chang Gung Memorial Hospital, Guishan, Taoyuan City, Taiwan. Electronic address:
Pan Afr Med J
December 2024
Department of Global Public Health, Karolinska Institutet, Stockholm, 17177, Sweden.
Cureus
November 2024
Public Health, Health Services Academy, Islamabad, PAK.
Background Monkeypox (Mpox) is a virulent disease caused by orthopoxvirus. Mpox is emerging as a major global health threat. Currently, more than 100 countries are facing outbreaks.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!